CODX.US Co-Diagnostics, Inc. Common Stock

Healthcare Health Care Equipment & Supplies USA Stocks
0.2607 USD
Close of Nov 13, 2026
0.2446 13.54
Market cap
USD 2.30M
P/E
-
P/B
0.25x
ROE
-307.4%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is CODX.US undervalued?

Graham number

The Graham number of Co-Diagnostics, Inc. Common Stock cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Co-Diagnostics, Inc. Common Stock fundamental analysis

No fundamental analysis for Co-Diagnostics, Inc. Common Stock yet.

Co-Diagnostics, Inc. Common Stock stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Co-Diagnostics, Inc. Common Stock

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. The company also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C,…

Full company profile